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tide chain containing 4536 amino acid residues, represents the protein moiety of low-density lipoproteins (LDL).4 Its gene, mapped on the short arm of chromosome 2 (1), has an approximate length of 43 kilobases (kb), and consists of 29 exons (2). Ape B-100 mediates the clearance of LDL from plasma by binding to the LDL Recently, a single-nucleotide mutation in codon 3500 in exon 26 of the ape B gene (COG to CAG) was described (5) . This mutation, which has a heterozygous frequency of -1/600, leads to substitution of glutamine for arginine in the variant gene product (6) . Individuals carrying the mutant allele in the heterozygous state are affected by a disorder termed 'tfamilial defective ape B-100" (FDB) , characterized by delayed clearance of LDL from plasma, hypercholesterolemia, and high concentrations of ape B in plasma (6) . This mutation supposedly alters the structural conformation of the protein in the vicinity of the receptor-binding domain, thus preventing the binding of LDL to the LDL receptor (7) . Because high concentrations of plasma cholesterol are associated with an increased risk for development of coronary heart disease (CHD) (8), FDB may represent an additional example of a genetic defect that predisposes carriers to this disease. To date, FDB subjects have been identified by use of either a monoclonal antibody that binds with higher affinity to the abnormal LDL (9) or radiolabeled allelespecific oligonucleotides that differentiate between the normal and mutant ape B allele by their alternative ability to form, under stringent conditions, stable homoduplexes with the allelic-gene segments that had been amplified by the polymerase chain reaction (PCR) (5) .
We describe here a method that further simplifies detection of the point mutation on codon 3500 of the ape B gene. This method is based on the selective creation of an artificial Msp I restriction site in the wild-type allele, but not in the mutant allele, by the use of sequencemodifying PCR primers. This principle was described previously in studies aimed at the detection of point Age 
Genomic Melting
Two oligonucleotides with the sequences 5'-AAGAG-CACACGGTCTFCAGTG3?
and 5'-AAGAGCACACAGTCTrCAGTG-3' were synthesized. 
Genomic RFLP Analysis
The Map I RFLP in codon 3611 was analyzed according to standard protocols (16,17) . A radiolabeled synthetic ape B oligonucleotide that spans a 50-bp region in exon 26 was used as a probe.
Results
The principle of RFLP-creating PCR with sequencemodifying primers for detecting the mutation in codon 3500 of ape B is illustrated in Figure 2 . Figure 3 shows the expected fragment lengths after cleavage and the deduced haplotypes.
Results from the analysis of a family with several carriers of the rare mutation in codon 3500 are shown in Figure 4 . In one member of the investigated family (subject F), only one 333-hp-long fragment was visible after digestion.
The presence of only this fragment is indicative of homozygosity for the wild-type allele at codon 3500 and the presence of the frequent allele at codon 3611. In subjects B, D, G, and H, a two-band pattern appeared with fragment lengths of 356 and 333 bp, which demonstrates the existence of heterozygosity at the 3500 site and homozygosity for the frequent allele at the 3611 site. Proband C, analyzed later, was found to carry the more frequent allele in both codons.
Subjects A and E were identified as heterozygous at both sites. They showed a three-band In all cases, this mutation was cis-localized with the frequent allele at codon 3611. All carriers showed moderate to severe hypercholesterolemia, and two had CHD. The other two haplotypes observed in this family were formed by the presence of the normal codon 3500, in phase with the frequent as well as the rare allele, at codon 3611. The analysis of five additional unrelated carriers of ape B (:Ql) showed that, also in these cases, this mutation was in phase with the presence of the Map I cutting site in codon 3611 (data not shown).
Restriction fragment length analysis of genomic DNA was used to confirm the presence or absence of the Map I site in codon3611 (data not shown). An oligonucleotide melting procedure with allele-specific oligonucleotides was used as an independent method for identifying the sequence variation in codon 3500 (data not shown). In all cases, the results obtained by these well-established procedures were in agreement with those from the analysis with sequence-modifying PCR primers.
Discussion
Here we have shown that the mutagenic PCR primer technique (10) allows reliable and rapid detection of ape a mutation in the ape B gene associated with hypercholesterolemia (6) . Moreover, we have demonstrated that this method can be used to determine the phase between two polymorphic sites.
The absence of recognition sequences for restriction enzymes that are formed or lost in the presence of either allele in codon 3500 of ape B prevents the use of RFLP analysis. Immunological and genetic methods that have been used previously to detect the codon 3500 mutation in ape B present disadvantages that limit their application to specialized laboratories. Such techniques as the use of monoclonal antibody MB47 (9) or allele-specific oligonucleotide hybridization (5, 18-20) are more laborious and time consuming than the PCR technique introduced by Kumar carriers have severe hypercholesterolemia; however, one proband with high concentrations of plasma cholesterol does not present this mutation. The underlying genetic defect for the hypercholesterolemic phenotype in this subject thus remains unclear.
The appearance of undigested PCR product, e.g., in lanes A and E of Figure 4 , is due to the formation of heteroduplexes during the later cycles of the PCR (22) . In these cases, after the denaturation step, the highly concentrated DNA strands re-anneal, outcompeting the PCR primers for hybridization to their complementary templates. The base mismatches in the heteroduplexes then prevent the cleavage by restriction enzymes. PCR amplification with a large excess of primer and fewer cycles abolishes this phenomenon (shown in the insert in Figure 4) . The presence of the fragment pattern observed in lanes A and E of Figure 4 is thus diagnostic for heterozygosity at both polymorphic sites and for their trans-localization on chromosome 2.
The method described may be generally applied for phase determination between two polymorphic sites located at distances that can be surpassed by a single PCR fragment.
The only requirement for a reliable phase determination is an absence, between the polymorphic sites, of additional recognition sequences for the enzyme used in detecting the polymorphisms. Problems potentially arising from the presence of additional phase-disrupting recognition sites may be overcome by introducing diagnostic restriction sites that are otherwise absent from the PCR product. Pre-existing restriction sites at the allelic site could be replaced with more suitable ones.
In conclusion, the successful application of the modifying PCR primer technique to the identification of carriers of ape B(3:Gtu) demonstrates that this method is suited for the rapid and reliable detection of carriers of known mutations. It may be generally useful in the assessment of genetic variation and associated clinical and biochemical consequences.
